In AD β-amyloid binds to and activates β2 adrenergic receptor signaling leading to subsequent activation of different serine and threonine protein kinases, which eventually result in enhanced tau phosphorylation [33]. The gene discussed is MAPT; the disease is Alzheimer disease.